Alpa Laboratories Ltd

Alpa Laboratories Ltd Share Price Today: Live Updates & Key Insights

Get insights on Alpa Laboratories Ltd’s fundamentals, financials, shareholding, peer comparison, corporate actions & performance. Track key metrics, price trends & market sentiment for informed decisions. Explore all data at Motilal Oswal.

Alpa Laboratories Ltd Share Price Chart

Alpa Laboratories Ltd Fundamentals

Traded Volume: 6,293

Market Cap(Cr): 165

Avg Traded Price 79.48

1 Year return -28.91%

Upper Circuit 81

Lower Circuit 78.5

P/E TTM 9.00

P/B Ratio 9.00

Traded Value(Cr) 4.95

EPS TTM 8.868

Book value 8.868

Dividend 0.00%

Alpa Laboratories Ltd Share Price Performance

Shows the percentage change in stock price over different time periods

This section highlights Alpa Laboratories Ltd stock price performance across key timeframes, including 1-week, 1-month, 3-month, Year-To-Date (YTD), and 1-year returns. It provides insights into the Alpa Laboratories Ltd share price history, short-term movements, long-term trends, and overall investor sentiment

1W -7.84%

1M -9.38%

3M -20.38%

1Y -28.91%

YTD -36.20%

Alpa Laboratories Ltd Traded Volume Movement

Shows the trading volume over different time periods

This section highlights Alpa Laboratories Ltd daily and average traded volumes, offering insights into investor activity and market liquidity. Higher volumes than average often indicate rising interest, news impact, or shifting market sentiment

Yesterday 16237.00

Day Before Yesterday 23429.00

1W Avg 22578.00

1M Avg 17840.90

3M Avg 15882.37

Alpa Laboratories Ltd Technical Details

Alpa Laboratories Ltd technical indicators, such as support and resistance levels and pivot points, are calculated based on historical price and volume trends. These metrics help traders anticipate possible price movements and make informed trading decisions.

Support 1 78

Support 2 77

Support 3 75

Pivot Point : 79

Resistance 1 80

Resistance 2 82

Resistance 3 83

Alpa Laboratories Ltd Corporate Actions

Alpa Laboratories Ltd corporate actions include dividends, bonus issues, stock splits, and key company updates that may affect share price and investor sentiment. This section provides timely details on past and upcoming actions, including ex-date, record date, and payout ratio - helping investors make informed decisions based on Alpa Laboratories Ltd’s capital allocation strategies.

All

Dividends

No Dividend has been declared by ALPA

Bonus

No Bonus has been declared by ALPA

Splits

No Split has been declared by ALPA

Others

Rights No Rights has been declared by ALPA

Alpa Laboratories Ltd Peer Comparison

Shows key financial metrics for the company and its peers

This section compares Alpa Laboratories Ltd with leading peers in the banking sector based on key metrics such as market capitalization, 1-year return, P/E (TTM), and PB ratio. It helps investors evaluate Alpa Laboratories Ltd's relative performance and valuation against major competitors.

Stock Name Advanced Enzyme Technologies Ltd ₹317.20 (-2.43%) M. Cap (Cr) 35.50 1 Yr Return (%) -14.48% P/E (TTM) 24.09 PB Ratio 2.65

Stock Name Panacea Biotec Ltd ₹345.15 (-3.21%) M. Cap (Cr) 21.14 1 Yr Return (%) -16.63% P/E (TTM) -292.00 PB Ratio 2.53

Stock Name Genesis IBRC India Ltd ₹158.30 (-1.98%) M. Cap (Cr) 2.06 1 Yr Return (%) NaN% P/E (TTM) -889.33 PB Ratio 24.12

Stock Name Alpa Laboratories Ltd ₹78.63 (-0.87%) M. Cap (Cr) 1.65 1 Yr Return (%) -28.91% P/E (TTM) 8.87 PB Ratio 0.97

Stock Name Bharat Immunological & Biological Corporation Ltd ₹20.20 (+0.40%) M. Cap (Cr) 0.87 1 Yr Return (%) -12.40% P/E (TTM) -4.72 PB Ratio 0.99

Stock Name Vivo Bio Tech Ltd ₹31.09 (-1.30%) M. Cap (Cr) 0.69 1 Yr Return (%) -18.38% P/E (TTM) 12.26 PB Ratio 0.82

Stock Name Shree Ganesh Biotech India Ltd ₹0.66 (-1.49%) M. Cap (Cr) 0.26 1 Yr Return (%) -36.54% P/E (TTM) 155.13 PB Ratio 0.41

Alpa Laboratories Ltd Cash Flow

Cash flow data provides a view of how money is generated and spent by Alpa Laboratories Ltd, across its operating activities, investing activities, and financing activities.

PARTICULARS Operating Activities Mar 2025 18.39 Mar 2024 3.70 Mar 2023 8.82 Mar 2022 2.20 Mar 2021 -1.45

PARTICULARS Investing Activities Mar 2025 -12.49 Mar 2024 -12.45 Mar 2023 2.14 Mar 2022 -17.18 Mar 2021 5.82

PARTICULARS Financing Activities Mar 2025 -5.48 Mar 2024 2.26 Mar 2023 -3.48 Mar 2022 5.41 Mar 2021 -0.03

PARTICULARS Net Cash Flow Mar 2025 0.43 Mar 2024 -6.49 Mar 2023 7.48 Mar 2022 -9.57 Mar 2021 4.34

Alpa Laboratories Ltd Shareholding Pattern

This shows the ownership breakdown of Alpa Laboratories Ltd, highlighting participation from Foreign Institutional Investors (FII), Mutual Funds, Public, Other Institutions, and Promoters.

Promoter 57.29%

Public 42.36%

Other Institutions 0.0%

FII 0.35%

Mutual Funds null%

About Alpa Laboratories Ltd

M/s Alpa Laboratories, formed in 1967, was incorporated as Private Limited Company in the name of Alpa Laboratories Private Limited on March 18, 1988 for manufacture of pharmaceutical formulations. In 1998, the Company was converted into a Public Limited Company with effect from September 3, 1998 with the name of "Alpa Laboratories Limited". The facility has dedicated manufacturing areas for different Finished Dosage Forms (FDFs) including liquid injections, dry injections, tablets, capsules, eye drops, ear drops, ointments, creams and gels. In 1997, the company has initiated setting of a new manufacturing unit at Rau(Indore District), Madhya Pradesh. The unit commenced commercial production in the year 1999 of all types of formulations viz. Injectables (Vials/Ampoules both liquid and Dry), tablets, capsules, eye/ear drops, ointment and creams. The company has manufacture a range of products such as ethical drugs, generic drugs, over the counter drugs (OTC) and veterinary products in various dosage forms and market them under the trade mark "Alpa" which is a registered trademark in the name of Alpa Labs (India) Limited, a promoter group company. The company has also manufacture formulations for a number of other pharmaceutical companies of national and international repute such as Cipla, Zydus Cadila, Lupin, Glenmark, Genom Biotech, Jenburkt, etc. (under their own brands) located both in India and abroad in countries such as Philippines, Iran, Iraq, Sierra Leon, Madagascar, Kenya, Liberia, Puerto Rico, Haiti, Sudan, Ghana, Nigeria, Srilanka etc. Further, the company has also undertaken contract manufacturing of a large variety of pharmaceuticals. The company has manufacture various dosage forms which include injectables (vials / ampoules both liquid and dry), tablets, capsules, eye / ear drops, ointment and creams and dry syrups. The company has an established product-marketing network covering both metro and mini metro cities, which enable company to reach the existing and potential customers through the network of distributors and dealers spread across the country. For the purpose of marketing the various products, the company`s business has been categorized as Branded Generic Division, Veterinary Division, Exports Division and Contract Manufacturing Division. The Company came out with an Initial Public Offer in July 2007 and got listed on The n The Bombay Stock Exchange and The National Stock Exchange on 06lh August, 2008. The Unit-II oral solid dosage manufacturing facility focusing on containment products such as oral hormonal and other oral hi-potency formulations was made operational at Pithampur Industrial Area in 2012. The Company in FY 2014-15, acquired 100% of the shares of Norfolk Mercantile Private Limited making it a wholly owned subsidiary.

Chairman & Exec. Director

Mahendra Singh Chawla

Registered office 33/2 Pigdamber, A B Road Rau, Indore, Madhya Pradesh, 453446

FAX :91-731-4294567

Background

Incorporation Year 1988

Face Value ₹10.00

Market Lot 1

Alpa Laboratories Ltd Latest News

VIEW MORE NEWS

FAQs on Alpa Laboratories Ltd